Current Trends in Device and Size Selection for Transcatheter Atrial Septal Defect Closure in Adults - Insights From

Akihito Tanaka1, Mitsuyoshi Takahara2, Shun Kohsaka3

  • 1Department of Cardiology, Nagoya University Graduate School of Medicine.

Insights

Transcatheter atrial septal defect (ASD) closure trends in adults show device selection and size impact outcomes. Device migration occurred rarely, irrespective of sizing, highlighting procedural safety in transcatheter ASD closure.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Investigates current trends in transcatheter atrial septal defect (ASD) closure for adult patients.
  • Focuses on device and size selection, and acute complications.
  • Utilizes data from the Japanese Structural Heart Disease (J-SHD) registry.

Purpose of the Study:

  • To analyze trends in transcatheter atrial septal defect (ASD) closure in adults.
  • To examine device and size selection strategies.
  • To report on acute complications associated with the procedure.

Main Methods:

  • Prospective nationwide multicenter registry analysis.
  • Inclusion of 1,921 adult patients undergoing transcatheter ASD closure (2019-2022).
  • Assessment of device type, size selection, and acute complications.

Main Results:

  • Mean age of participants was 57±18 years; 37.6% were male.
  • Aortic rim deficiency present in 50.3% of patients.
  • Device migration occurred in 0.4% of patients, unrelated to sizing.

Conclusions:

  • Reports trends in clinical features, device/size selection, and acute complications for adult transcatheter ASD closure.
  • Highlights device-specific prevalence of aortic rim deficiency.
  • Indicates low incidence of device migration regardless of sizing.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
539
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
599
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
479